Keyphrases
Cyclic GMP
100%
Multi-Ethnic Study of Atherosclerosis
100%
Left Ventricular Mass
100%
Cardiovascular Risk
18%
Cardiovascular Disease
18%
Cardiac Magnetic Resonance Imaging (cMRI)
9%
Sex Differences
9%
Community-based Cohort
9%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
9%
Natriuretic Peptides
9%
Second Messenger
9%
Nitric Oxide Signaling
9%
B-type
9%
Heart Failure Disease
9%
ProB
9%
Mass Change
9%
Mechanistic Role
9%
Compensatory Changes
9%
LV Remodeling
9%
Medicine and Dentistry
Atherosclerosis
100%
Cyclic GMP
100%
Cardiovascular Disease
18%
Cardiovascular Disease Risk Factor
18%
Amino Terminal Sequence
18%
Cardiac Magnetic Resonance Imaging
9%
Nitric Oxide
9%
Brain Natriuretic Peptide
9%
Natriuretic Factor
9%
Sex Difference
9%
Heart Failure
9%
Second Messenger
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
100%
Cyclic GMP
100%
Cardiovascular Disease
36%
Nitric Oxide
9%
Natriuretic Factor
9%
Brain Natriuretic Peptide
9%
Heart Failure
9%
Biochemistry, Genetics and Molecular Biology
Cyclic Guanosine Monophosphate
100%
Heart Left Ventricle Mass
100%
N-Terminus
18%
Natriuretic Peptide
18%
Sex Difference
9%
Nitric Oxide
9%
Second Messenger System
9%
Psychology
Magnetic Resonance Imaging
100%
Sex Differences
100%
Neuroscience
Cyclic Guanosine Monophosphate
100%
Amino Terminal Sequence
18%
Nitric Oxide
9%
Cardiac Magnetic Resonance Imaging
9%
Second Messenger System
9%
Natriuretic Peptide
9%
Brain Natriuretic Peptide
9%